|Bid||19.00 x 1000|
|Ask||21.00 x 800|
|Day's Range||21.30 - 21.90|
|52 Week Range||20.29 - 54.42|
|Beta (5Y Monthly)||-1.61|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 05, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||41.00|
Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products which are used to treat patients of all ages suffering from respiratory distress, today announced first quarter 2021 financial results.
NEW YORK, NY / ACCESSWIRE / May 5, 2021 / Vapotherm, Inc. (NYSE:VAPO) will be discussing their earnings results in their 2021 First Quarter Earnings call to be held on May 5, 2021 at 4:30 PM Eastern Time.
Vapotherm (VAPO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.